| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1980;30:378-384
© 1980 The Society of Thoracic Surgeons
From the Departments of Thoracic Surgery and Lung Medicine, University Hospital, Uppsala, Sweden
Accepted for publication January 18, 1980.
* Address reprint requests to Dr. Åberg, Department of Thoracic Surgery, University Hospital, 750 14 Uppsala 14, Sweden
Metastasectomy in the treatment of solitary metastases has been recommended almost unanimously. The basis for this recommendation has been that 5-year survival after metastasectomy is around 30%, which is just as good as after operation for bronchial carcinoma. It has been assumed, implied, or claimed that the 5-year survival without operation is nil. Control material is, however, lacking.
Seventy surgically treated patients were compared with a small, historical control group of 12 patients. There was no difference in 5-year survival. Because of these findings and after a study of the literature, we postulate that patients with lung metastases fulfilling the criteria for operation constitute a selected group with a favorable natural history. Five-year survival, therefore, is an insufficient way of describing the effect of metastasectomy. However, patients with 10-year survival are rare in the literature.
In some patients with a favorable tumor-host relationship or with possibilities for effective chemotherapy, cure or prolongation of life has been achieved. Such patients should undergo operation. Randomized studies are needed in all groups for which we do not have sufficiently strong evidence that metastasectomy contributes to the longevity of the patient.
This article has been cited by other articles:
|
|
 |
|
  F. Fiorentino, I. Hunt, K. Teoh, T. Treasure, and M. Utley Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis J R Soc Med, February 1, 2010; 103(2): 60 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Treasure Are randomised trials needed in the era of rapidly evolving technologies? Eur J Cardiothorac Surg, March 1, 2009; 35(3): 474 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Treasure Editorial comment: Surgical resection of pulmonary metastases Eur J Cardiothorac Surg, August 1, 2007; 32(2): 354 - 355. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pfannschmidt, H. Dienemann, and H. Hoffmann Surgical Resection of Pulmonary Metastases From Colorectal Cancer: A Systematic Review of Published Series Ann. Thorac. Surg., July 1, 2007; 84(1): 324 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Jaklitsch, C. M. Mery, J. M. Lukanich, W. G. Richards, R. Bueno, S. J. Swanson, S. J. Mentzer, B. D. Davis, E. N. Allred, and D. J. Sugarbaker Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 657 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Aberg Selection Mechanisms as Major Determinants of Survival After Pulmonary Metastasectomy Ann. Thorac. Surg., March 1, 1997; 63(3): 611 - 612. [Full Text]
|
|
|
|
|
|
J. H. Robert, V. Ambrogi, B. Mermillod, D. Dahabreh, and P. Goldstraw Factors Influencing Long-Term Survival After Lung Metastasectomy Ann. Thorac. Surg., March 1, 1997; 63(3): 777 - 784. [Abstract] [Full Text]
|
|
|
|
|
|
J. B. Putnam Jr., J. A. Roth, M. N. Wesley, M. R. Johnston, and S. A. Rosenberg Survival Following Aggressive Resection of Pulmonary Metastases from Osteogenic Sarcoma: Analysis of Prognostic Factors Ann. Thorac. Surg., November 1, 1983; 36(5): 516 - 523. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
